NCT00309244 · Interventional trial
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
Overall registry status Completed
Phase 3
Conditions Diabetes Type 2
Delaware Valley sites
- Pennsylvania Research Institute · Bensalem, PA · Bucks County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory